Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against AbbVie, Inc. Pharmaceutical Investing
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CELH, VLTA and ABBV Pharmaceutical Investing
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of AbbVie Inc. Investors Pharmaceutical Investing
ABBV SHAREHOLDER ALERT: Jakubowitz Law Reminds AbbVie Shareholders of a Lead Plaintiff Deadline of June 6, 2022 Pharmaceutical Investing
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages AbbVie Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
Nektar and Bristol Myers Squibb Announce Update on Clinical Development Program for Bempegaldesleukin in Combination with Opdivo Pharmaceutical Investing
Gilead Sciences to Release First Quarter 2022 Financial Results on Thursday, April 28, 2022 Pharmaceutical Investing
CLASS ACTION UPDATE for CELH, GRAB and ABBV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
SHAREHOLDER ALERT: MP CELH ABBV: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines Pharmaceutical Investing
LAWSUITS FILED AGAINST TASK, CELH and ABBV - Jakubowitz Law Pursues Shareholders Claims Pharmaceutical Investing
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of AbbVie Inc. Investors Pharmaceutical Investing
